Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPT-Prevent-pilot: Lisinopril and Pacing Optimization for LV Remodeling
NCT03422705Phase 2Unknown
- Sponsor
- University of Leeds
- Start
- Dec 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lisinopril in Left ventricular remodeling (LVR), heart failure (HF), sponsored by University of Leeds. Status: unknown.
02
Drugs
lisinopril
03
Conditions
Left ventricular remodeling (LVR)heart failure (HF)
Beyond the preview
Go deeper on NCT03422705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422705.